As the world reaches the midpoint of the Immunization Agenda 2030 (IA2030), immunization programs find themselves at an inflection point.1 The initial focus on recovering from pandemic-era backsliding is giving way to a more complex agenda: simultaneously catching up with missed cohorts, sustaining high coverage, integrating new vaccines, managing climate and conflict-driven shifts in disease epidemiology, and rebuilding confidence in an era of politicized health.1–3 This transition from “recovery” to “resilience” will be the defining challenge for ministries of health, front-line clinicians and industry partners over the next five years.1–3 The IA2030 mid-term review: a mixed report card The IA2030 mid term review reaffirms the vision of a world where everyone, everywhere, at every age, fully benefits from vaccines, but it also documents persistent gaps.1 Core coverage for traditional childhood antigens has not returned to pre-pandemic levels in many countries, and global targets such as at least 90% coverage and a 50% reduction in zero-dose children remain distant...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!
As long as you call theCOVID shots vaccines and ignore the paramount damage done to global health by these gen-alterating drugs you won´t be able to rebuild trust neither into “classical” vaccines in detail nor into science or medical services in general – as a pro-vaxxer and anti-spiker I am challenged by this merely every day. I predicted it already 5 years ago and – sad to say – I was right! Martin Haditsch
P.S.: I was bullied, cornered, framed, censored, sued … but there is the power of facts – truth comes to light, thus the desaster cannot be hidden any longer.
Dear Dr. Haditsch,
thank you for sharing your perspective and for your continued engagement with vaccination issues, especially given the pressures you describe. Global data, however, show a more positive picture than the one you report. In most regions – particularly many low and middle income countries and much of Asia – the majority of people remain in favor of vaccination in general and COVID 19 vaccination in particular, with opposition most concentrated in specific high income settings. In that sense, your very real daily frustrations seem strongly shaped by your local context and are not fully representative of global attitudes.
It is scientific and regulatory consensus is that mRNA vaccines do not integrate into the human genome; if you consider there to be robust evidence to the contrary, it would be valuable if you could share the evidence.
My goal with the IA2030 coverage is precisely to hold those two realities together: to acknowledge genuine harms, uncertainties and mistrust in some places, while also reflecting the substantial, measurable vaccine confidence that still exists in many parts of the world.
Kind regards,
JOE SCHMITT